Search

everythinglearnresearchcommunity

for

Search:↓

Being overweight or obese before pregnancy increases the risk of having a C-section and a larger-than-normal baby in Chile's public health system.

The peach gene pCTG134 helps control the interaction between auxin and ethylene hormones during fruit ripening.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

A man lost all his hair as a rare side effect after hepatitis C treatment.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Rat whisker cells can help turn other cells into nerve cells and might be used to treat brain injuries or diseases.

A new mRNA variant of the SCF gene in sheep skin produces a shorter, different protein.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Human hair follicle cells can grow hair when put into mouse skin if they stay in contact with mouse cells.